• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

CD4淋巴细胞计数的进展建模及其与生存时间的关系。

Modelling progression of CD4-lymphocyte count and its relationship to survival time.

作者信息

De Gruttola V, Tu X M

机构信息

Department of Biostatistics, Harvard School of Public Health, Boston, Massachusetts 02115.

出版信息

Biometrics. 1994 Dec;50(4):1003-14.

PMID:7786983
Abstract

The purpose of this article is to model the progression of CD4-lymphocyte count and the relationship between different features of this progression and survival time. The complicating factors in this analysis are that the CD4-lymphocyte count is observed only at certain fixed times and with a high degree of measurement error, and that the length of the vector of observations is determined, in part, by the length of survival. If probability of death depends on the true, unobserved CD4-lymphocyte count, then the survival process must be modelled. Wu and Carroll (1988, Biometrics 44, 175-188) proposed a random effects model for two-sample longitudinal data in the presence of informative censoring, in which the individual effects included only slopes and intercepts. We propose methods for fitting a broad class of models of this type, in which both the repeated CD4-lymphocyte counts and the survival time are modelled using random effects. These methods permit us to estimate parameters describing the progression of CD4-lymphocyte count as well as the effect of differences in the CD4 trajectory on survival. We apply these methods to results of AIDS clinical trials.

摘要

本文的目的是对CD4淋巴细胞计数的变化过程以及该变化过程的不同特征与生存时间之间的关系进行建模。该分析中的复杂因素在于,CD4淋巴细胞计数仅在某些固定时间进行观测,且存在高度的测量误差,并且观测向量的长度部分取决于生存时间的长短。如果死亡概率取决于真实的、未观测到的CD4淋巴细胞计数,那么就必须对生存过程进行建模。Wu和Carroll(1988年,《生物统计学》44卷,175 - 188页)针对存在信息删失情况下的两样本纵向数据提出了一种随机效应模型,其中个体效应仅包括斜率和截距。我们提出了用于拟合这类广泛模型的方法,其中使用随机效应同时对重复的CD4淋巴细胞计数和生存时间进行建模。这些方法使我们能够估计描述CD4淋巴细胞计数变化过程的参数,以及CD4轨迹差异对生存的影响。我们将这些方法应用于艾滋病临床试验的结果。

相似文献

1
Modelling progression of CD4-lymphocyte count and its relationship to survival time.CD4淋巴细胞计数的进展建模及其与生存时间的关系。
Biometrics. 1994 Dec;50(4):1003-14.
2
Zidovudine therapy, CD4+ and CD8+ counts are associated with a longer survival following AIDS onset.齐多夫定治疗、CD4 + 和 CD8 + 细胞计数与艾滋病发病后更长的生存期相关。
Lymphology. 1997 Sep;30(3):128-36.
3
A semiparametric Bayesian approach to the random effects model.一种用于随机效应模型的半参数贝叶斯方法。
Biometrics. 1998 Sep;54(3):921-38.
4
Evaluating surrogate markers of clinical outcome when measured with error.在存在测量误差的情况下评估临床结局的替代标志物。
Biometrics. 1998 Dec;54(4):1445-62.
5
Demystifying optimal dynamic treatment regimes.揭开最优动态治疗方案的神秘面纱。
Biometrics. 2007 Jun;63(2):447-55. doi: 10.1111/j.1541-0420.2006.00686.x.
6
Interruption of antiretroviral treatment in HIV-infected patients with preserved immune function is associated with a low rate of clinical progression: a prospective study by AIDS Clinical Trials Group 5170.免疫功能良好的HIV感染患者中断抗逆转录病毒治疗与临床进展率较低相关:艾滋病临床试验组5170的一项前瞻性研究
J Infect Dis. 2007 May 15;195(10):1426-36. doi: 10.1086/512681. Epub 2007 Apr 6.
7
Estimating the parameters in the Cox model when covariate variables are measured with error.当协变量变量存在测量误差时,估计Cox模型中的参数。
Biometrics. 1998 Dec;54(4):1407-19.
8
The relationship between virologic and immunologic responses in AIDS clinical research using mixed-effects varying-coefficient models with measurement error.在艾滋病临床研究中,使用带有测量误差的混合效应变系数模型研究病毒学与免疫学反应之间的关系。
Biostatistics. 2003 Apr;4(2):297-312. doi: 10.1093/biostatistics/4.2.297.
9
Immunologic markers of AIDS progression: consistency across five HIV-infected cohorts. Multicohort Analysis Project Workshop. Part I.艾滋病进展的免疫标志物:五个艾滋病毒感染队列的一致性。多队列分析项目研讨会。第一部分。
AIDS. 1994 Jul;8(7):911-21.
10
Interruption of combination antiretroviral therapy and risk of clinical disease progression to AIDS or death.联合抗逆转录病毒治疗中断与临床疾病进展至艾滋病或死亡的风险。
HIV Med. 2007 Mar;8(2):96-104. doi: 10.1111/j.1468-1293.2007.00436.x.

引用本文的文献

1
Integrative Multi-Omics and Multivariate Longitudinal Data Analysis for Dynamic Risk Estimation in Alzheimer's Disease.用于阿尔茨海默病动态风险评估的整合多组学与多变量纵向数据分析
Stat Med. 2025 May;44(10-12):e70105. doi: 10.1002/sim.70105.
2
JOINT MODELING OF MULTISTATE AND NONPARAMETRIC MULTIVARIATE LONGITUDINAL DATA.多状态与非参数多变量纵向数据的联合建模
Ann Appl Stat. 2024 Sep;18(3):2444-2461. doi: 10.1214/24-aoas1889. Epub 2024 Aug 5.
3
Exposure proximal immune correlates analysis.暴露近端免疫相关分析。
Biostatistics. 2024 Dec 31;26(1). doi: 10.1093/biostatistics/kxae031.
4
Bayesian joint models for multi-regional clinical trials.贝叶斯联合模型在多区域临床试验中的应用。
Biostatistics. 2024 Jul 1;25(3):852-866. doi: 10.1093/biostatistics/kxad023.
5
Fast and flexible inference for joint models of multivariate longitudinal and survival data using integrated nested Laplace approximations.使用集成嵌套拉普拉斯近似法对多元纵向和生存数据的联合模型进行快速灵活的推断。
Biostatistics. 2024 Apr 15;25(2):429-448. doi: 10.1093/biostatistics/kxad019.
6
Joint modelling of longitudinal response and time-to-event data using conditional distributions: a Bayesian perspective.基于条件分布的纵向响应与事件发生时间数据的联合建模:贝叶斯视角
J Appl Stat. 2021 Mar 9;49(9):2228-2245. doi: 10.1080/02664763.2021.1897971. eCollection 2022.
7
Adherence to contemporary antiretroviral treatment regimens and impact on immunological and virologic outcomes in a US healthcare system.在一个美国医疗体系中,对当代抗逆转录病毒治疗方案的坚持与免疫和病毒学结果的影响。
PLoS One. 2022 Feb 14;17(2):e0263742. doi: 10.1371/journal.pone.0263742. eCollection 2022.
8
Bayesian semiparametric joint modeling of longitudinal explanatory variables of mixed types and a binary outcome.贝叶斯半参数混合类型纵向解释变量和二项结局的联合建模。
Stat Med. 2022 Jan 15;41(1):17-36. doi: 10.1002/sim.9221. Epub 2021 Oct 17.
9
Falls: a marker of preclinical Alzheimer disease: a cohort study protocol.跌倒:临床前阿尔茨海默病的标志物:一项队列研究方案。
BMJ Open. 2021 Sep 15;11(9):e050820. doi: 10.1136/bmjopen-2021-050820.
10
Assessing Importance of Biomarkers: a Bayesian Joint Modeling Approach of Longitudinal and Survival Data with Semicompeting Risks.评估生物标志物的重要性:一种具有半竞争风险的纵向和生存数据的贝叶斯联合建模方法。
Stat Modelling. 2021 Feb 1;21(1-2):30-55. doi: 10.1177/1471082x20933363. Epub 2020 Jul 27.